And the Chinese ccp. And you are very concerned about that. Why are you worried about that? Well, here's what we've done. Over the last 30 years, the drug production in this country has moved from here, where the FDA actually inspects the plants to Russia to China and India with most ingredients coming out of China where there's basically no inspections. Right. We know from studies that it's not safe. We know that they can cut it off like they did with PPP after Covid, like they've threatened to do with rare earth. (00:46–01:04)
CLAIM
Asserts that drug production has moved to countries with less FDA oversight, primarily China.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
